Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384

PURPOSE: Radiation remains a mainstay for the treatment of non-metastatic head and neck squamous cell carcinoma (HNSCC), a malignancy characterized by a high rate of PI3K/mTOR signaling axis activation. We investigated the ATP-competitive dual PI3K/mTOR inhibitor, PF-05212384, as a radiosensitizer i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Leiker, Andrew J., DeGraff, William, Choudhuri, Rajani, Sowers, Anastasia L., Thetford, Angela, Cook, John A., Van Waes, Carter, Mitchell, James B.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4470749/
https://ncbi.nlm.nih.gov/pubmed/25724523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-3279
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki